GL1X · GenesisL1 explorer

MolNFT v1 · #116657 · protein

Crystal structure of the bromodomain of human BRG1 (SMARCA4) in complex with pfi-3 chemical probe

5DKD · Transcription activator BRG1: “Crystal structure of the bromodomain of human BRG1 (SMARCA4) in complex with pfi-3 chemical probe”. X-ray diffraction, 2 ligands (5BW, ZN), 3 pockets (best druggability 0.48). MolNFT v1 #116657 on…

PDB
5DKD
Type
protein
Length
220 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transcription activator BRG1
EC
3.6.4.-
UniProt
P51532
Ligands
5BW, ZN
Pockets
3 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 65% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTranscription activator BRG1 (EC 3.6.4.-)protein11065% helix, 2% strandP51532

Ligands and binding sites

  • 5BW · (2E)-1-(2-hydroxyphenyl)-3-[(1R,4R)-5-(pyridin-2-yl)-2,5-diazabicyclo[2.2.1]hept-2-yl]prop-2-en-1-one · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1550.480.85145BW
21660.440.7526empty
31310.380.7415empty

Interfaces

1 interface between chains.

  • A–B · 320 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 5DKD · Crystal structure of the bromodomain of human BRG1 (SMARCA4) in complex with PFI-3… · the same entry in another collection · chain A against A, TM-score 1.00
  • P51532 · AlphaFold monomer V2.0 prediction for transcription activator BRG1 (P51532) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.